Form 4 holding
EVP & Chief Business Officer, Director
BRAINSTORM CELL THERAPEUTICS INC.
- Security class
- Common Stock
- Shares / value
- 218,464
- Estimated value
- $15,610
- Report date
- 26 Feb 2026
- Price
- $0.2280
- Ownership
- Direct